Södertälje, Sweden

Anna-Karin Tidén


 

Average Co-Inventor Count = 2.1

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Loughborough, GB (2011)
  • Södertälje, SE (2008 - 2014)
  • Sodertalje, SE (2010 - 2017)

Company Filing History:


Years Active: 2008-2017

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Anna-Karin Tidén

Introduction

Anna-Karin Tidén is a prominent inventor based in Södertälje, Sweden. She has made significant contributions to the field of pharmaceuticals, particularly in the development of novel therapeutic compounds. With a total of four patents to her name, her work focuses on addressing critical health issues through innovative solutions.

Latest Patents

Among her latest patents, Tidén has developed Pyrrolo[3,2-D]pyrimidin-4-one derivatives and their use in therapy. These compounds are designed to inhibit the enzyme MPO, making them particularly useful in treating neuroinflammatory disorders, cardiovascular disorders, and respiratory disorders. Additionally, she has created pyrimidine derivatives that possess immune-modulating properties, acting via TLR7 for the treatment of viral or allergic diseases and cancers. These inventions include processes for their preparation, pharmaceutical compositions, and their therapeutic applications.

Career Highlights

Throughout her career, Anna-Karin Tidén has worked with notable companies such as AstraZeneca AB and Dainippon Sumitomo Pharma Co., Ltd. Her experience in these organizations has allowed her to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Tidén has collaborated with esteemed colleagues, including Anders Bögevig and Yvonne Lo-Alfredsson. These partnerships have further enhanced her innovative work and expanded the impact of her inventions.

Conclusion

Anna-Karin Tidén's contributions to the field of pharmaceuticals through her patents and collaborations highlight her role as a leading inventor. Her work continues to pave the way for advancements in therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…